[News]LEESOL Secures 4 Billion KRW Series A Investment
11 Jun 2026
LEESOL, a healthcare startup operating an electronic medicine platform for the prevention, diagnosis, and treatment of brain diseases, announced on the 2nd that it has secured a 4 billion KRW Series A investment from venture capital (VC) firms and pharmaceutical companies, including Vine Ventures and Kolon Pharmaceuticals. This investment attraction comes about a year after receiving a 500 million KRW Pre-A investment from New Paradigm Investment last year. Notably, this investment is highly significant as it was achieved amid a challenging funding environment for the pharmaceutical and biotech sectors.
LEESOL, a healthcare startup operating an electronic medicine platform for the prevention, diagnosis, and treatment of brain diseases, announced on the 2nd that it has secured a 4 billion KRW Series A investment from venture capital (VC) firms and pharmaceutical companies, including Vine Ventures and Kolon Pharmaceuticals. This investment attraction comes about a year after receiving a 500 million KRW Pre-A investment from New Paradigm Investment last year. Notably, this investment is highly significant as it was achieved amid a challenging funding environment for the pharmaceutical and biotech sectors.
Go to News